Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 1/2 5Phase 3 3Phase 2/3 2

Status

Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 10Stomach Neoplasms 5Colonic Neoplasms 5Carcinoma, Hepatocellular 4Rectal Neoplasms 3Pancreatic Neoplasms 2Neoplasms 2Lung Neoplasms 2Gastrointestinal Neoplasms 2Biliary Tract Neoplasms 2Vipoma 1Somatostatinoma 1Resected Liver Metastases From Colorectal Cancer 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pathologic Complete Response 1Neutropenia 1Neuroendocrine Tumors 1Malignant Tumor of Pancreas Metastatic to Liver 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia 1Insulinoma 1Glucagonoma 1Gestational Trophoblastic Disease 1Gastrinoma 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Diarrhea 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Islet Cell 1

Interventions

Gemcitabine 4Cisplatin 4Capecitabine 4Oxaliplatin 3Leucovorin 2Fluorouracil 2Albumin-Bound Paclitaxel 2titanium silicide 1tegafur-gimeracil-oteracil 1surufatinib 1pembrolizumab 1mitazalimab 1durvalumab 1cediranib 1anlotinib 1Taxes 1S 1 (combination) 1Paclitaxel 1Folfox protocol 1Control Groups 1ARRY-334543 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Biliary Tract Neoplasms × Leucovorin × Clear all
NCT07437287 2026-02-27

CROCOBIL

UNICANCER

Phase 2/3 Not yet recruiting
160 enrolled
Gastrointestinal

Biliary Tract Neoplasms

NCT06662877 2024-10-29

Anlotinib Plus Nab-Paclitaxels and S-1 for Patients with Advanced Biliary Tract Cancer As Second-Line Treatment

Sun Yat-sen University

Phase 2/3 Not yet recruiting
206 enrolled
Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡